Home/GreenJay Therapeutics/Lisa Bollinger, MD
LB

Lisa Bollinger, MD

Advisor (FDA Strategy)

GreenJay Therapeutics

Roles

Advisor (FDA Strategy)atGreenJay Therapeutics
Board MemberatApogee Therapeutics

Therapeutic Areas

GreenJay Therapeutics Pipeline

DrugIndicationPhase
Bulanta™Conditioning agent for stem cell transplantation in Chronic Myelogenous Leukemia (CML)Pre-NDA